Peptide news

Peptide price index, October 2026: NAD+ from $97, sermorelin and glutathione from $99 a month on our chart

Published November 5, 2026. Prices as of October 31, 2026.

In October 2026 the lowest monthly cash price on our chart was $97 for NAD+ at BiltRx, $99 for sermorelin at Embody and $99 for glutathione at Heally.

Cheapest NAD+ this week

  1. CoreAge Rx logoCoreAge Rxfrom $93 a month, no membership fee. No long-term contractNAD+ injectionChecked November 21, 2026 on CoreAge Rx's own pageCheck price at CoreAge Rx →
  2. CoreAge Rx logoCoreAge Rxfrom $93 a month, no membership fee. No long-term contractNAD+ nasal sprayChecked November 21, 2026 on CoreAge Rx's own pageCheck price at CoreAge Rx →

Prices checked by The Pep Chart on , from each program's own page. How we check prices | How we make money

Prices checked by The Pep Chart on , from each program's own page. How we check prices | How we make money

Programs pay us when you sign up through our links. Affiliate disclosure

We read each program's own pricing page every week, and the October index fixes the month on October 31. Each figure below carries the condition the program prints beside it.

NAD+ ran from $97 a month at BiltRx, with the consultation and shipping billed separately, up to $229. Sermorelin ran from $99 to $330 a month. Embody charges $49 for the first month and then $99, Lttl starts at $99 with visits included, and Strut Health sells a sermorelin lozenge at $99 a month on auto-refill. Glutathione ran from $99 at Heally, billed when you reorder, to $162.

The spread inside one peptide is wide, so the program matters more than the peptide. Check what the price covers: the visit, shipping and whether it renews on its own.

Every price this week is on the home chart, and the full month is on the peptide price index.

Sources

  • BiltRx NAD+ injection (biltrx.com), read October 31, 2026. Our saved copy.
  • Embody sermorelin (sermorelin.joinem.co), read October 30, 2026. Our saved copy.

Every peptide price: the NAD+ chart and the peptide price index.

Not medical advice.

FDA status

NAD is on the FDA's Category 1 list, substances pharmacies may compound while the agency reviews them.

FDA status of every peptide we track